Benzodiazepine Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)

The benzodiazepine drugs market is expected to grow at a CAGR of 2.29% during the forecast period 2023-2030.

North America is expected to dominate the global benzodiazepine drugs market due to several factors, including a higher number of FDA approvals, increasing awareness of mental health disorders, and a growing geriatric population.

The key segments of the benzodiazepine drugs market are by product, time of action, application, distribution channel, and region. Among these, the anxiety disorders segment is expected to hold the largest share due to the rising prevalence of anxiety disorders globally.

Some of the key players in the global benzodiazepine drugs market include Pfizer Inc., Bausch Health Companies, Inc., Teva Pharmaceutical Industries Ltd., AdvaCare Pharma, H.Lundbeck A/S, Amneal Pharmaceuticals LLC, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals (West-Ward Pharmaceuticals), Dash Pharmaceuticals LLC, and Intas Pharmaceuticals Limited.